The store will not work correctly when cookies are disabled.
(5-Amino-3-(pyridin-2-yl)-1H-1,2,4-triazol-1-yl)(3,4-dimethylphenyl)-methanone
ID: ALA4777212
PubChem CID: 162643031
Max Phase: Preclinical
Molecular Formula: C16H15N5O
Molecular Weight: 293.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(C(=O)n2nc(-c3ccccn3)nc2N)cc1C
Standard InChI: InChI=1S/C16H15N5O/c1-10-6-7-12(9-11(10)2)15(22)21-16(17)19-14(20-21)13-5-3-4-8-18-13/h3-9H,1-2H3,(H2,17,19,20)
Standard InChI Key: DZGOQOXWBUEYTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
3.3994 -5.7863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3983 -6.6059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1063 -7.0148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8160 -6.6054 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8132 -5.7827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1045 -5.3775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5171 -5.3731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2649 -5.7027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8094 -5.0933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3981 -4.3871 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5995 -4.5601 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6224 -5.1757 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7276 -3.6393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5400 -3.5508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2447 -2.9800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0209 -4.2112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8325 -4.1230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1628 -3.3746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6753 -2.7135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8653 -2.8049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0022 -1.9645 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9750 -3.2850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 1 0
11 7 2 0
5 7 1 0
9 12 1 0
10 13 1 0
13 14 1 0
13 15 2 0
14 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 14 1 0
19 21 1 0
18 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 293.33 | Molecular Weight (Monoisotopic): 293.1277 | AlogP: 2.23 | #Rotatable Bonds: 2 |
Polar Surface Area: 86.69 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.96 | CX LogD: 3.96 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.78 | Np Likeness Score: -1.76 |
References
1. Korff M,Imberg L,Will JM,Bückreiß N,Kalinina SA,Wenzel BM,Kastner GA,Daniliuc CG,Barth M,Ovsepyan RA,Butov KR,Humpf HU,Lehr M,Panteleev MA,Poso A,Karst U,Steinmetzer T,Bendas G,Kalinin DV. (2020) Acylated 1H-1,2,4-Triazol-5-amines Targeting Human Coagulation Factor XIIa and Thrombin: Conventional and Microscale Synthesis, Anticoagulant Properties, and Mechanism of Action., 63 (21): [PMID:33089691] [10.1021/acs.jmedchem.0c01635] |